COVID-19 Records

Re: IVIg Protocol Team

Gates Package, pp.794-795 · gates:email:00720

Page text: p.794, p.795 · original PDF

Date
2020-04-18 19:22
Type
email · email
sender
H. Clifford Lane
to
Jim Neaton
Topics
Intelligence community assessmentsTherapeutics and treatments
Yes - outstanding physician. On Apr 18, 2020, at 7:14 PM, Jim Neaton @umn.edu> wrote: I recognize the name - was she involved in ESPRIT? On Sat, Apr 18, 2020 at 6:12 PM Lane, Cliff (NIH/NIAID) [E] @niaid.nih.gov> wrote: I think Mark knows her well. She used to work with Praphan and Kiat. On Apr 18, 2020, at 7:10 PM, Jim Neaton @umn.edu> wrote:  Thanks for the introduction Penny, and nice to meet you Jintanat. Look forward to talking to you on Wednesday and working on the protocols with you. Jim On Sat, Apr 18, 2020 at 4:43 PM Penny Heaton @gatesmri.org> wrote: Dear Cliff and Jim, Greetings! I hope this weekend finds you with at least a moment to relax. By way of this email, I would like to introduce you to Jintanat Ananworanich. She is a pediatrician and immunologist, currently co-leading our RSV monoclonal antibody program among others. She has much clinical trial experience, particularly in LMICs. She declares she has a some additional bandwidth and would love to join you on the weekly team calls and help in any way she can. I will leave it to the three of you to coordinate from here. Best, Penny

Extracted statements

Rule-extracted, not adjudicated. The grade says what may be done with each one; read the document above before relying on any of them.

StatementGradeAttributionStance
She is a pediatrician and immunologist, currently co-leading our RSV monoclonal antibody program among others. quoted / not their view quoted_external message body appears to be pasted content asserts

In context

A single line often inverts meaning once you see what it answers, so neighbouring messages are always shown.

  1. 2020-04-18 19:10 Jim Neaton open
    Attention: This message was sent from an external domain. Thanks for the introduction Penny, and nice to meet you Jintanat. Look forward to talking to you on Wednesday and working on the protocols with you. Jim On Sat, Apr 18, 2020 at 4:43 PM Penny Heaton @gatesmri.org> wrote: Dear Cliff and Jim, Greetings! I hope this weekend finds you with at least a moment to relax. By way of this email, I would like to introduce you to Jintanat Ananworanich. She is a pediatrician and immunologist, currently co-leading our RSV monoclonal antibody program among others. She has much clinical trial experience, particularly in LMICs. She declares she has a some additional bandwidth and would love to join you on the weekly team calls and help in any way she can. I will leave it to the three of you to coordinate from here. Best, Penny
  2. 2020-04-18 19:12 H. Clifford Lane open
    I think Mark knows her well. She used to work with Praphan and Kiat. On Apr 18, 2020, at 7:10 PM, Jim Neaton @umn.edu> wrote: Thanks for the introduction Penny, and nice to meet you Jintanat. Look forward to talking to you on Wednesday and working on the protocols with you. Jim On Sat, Apr 18, 2020 at 4:43 PM Penny Heaton @gatesmri.org> wrote: Dear Cliff and Jim, Greetings! I hope this weekend finds you with at least a moment to relax. By way of this email, I would like to introduce you to Jintanat Ananworanich. She is a pediatrician and immunologist, currently co-leading our RSV monoclonal antibody program among others. She has much clinical trial experience, particularly in LMICs. She declares she has a some additional bandwidth and would love to join you on the weekly team calls and help in any way she can. I will leave it to the three of you to coordinate from here. Best, Penny
  3. 2020-04-18 19:14 Jim Neaton open
    I recognize the name - was she involved in ESPRIT? On Sat, Apr 18, 2020 at 6:12 PM Lane, Cliff (NIH/NIAID) [E] @niaid.nih.gov> wrote: I think Mark knows her well. She used to work with Praphan and Kiat. On Apr 18, 2020, at 7:10 PM, Jim Neaton @umn.edu> wrote:  Thanks for the introduction Penny, and nice to meet you Jintanat. Look forward to talking to you on Wednesday and working on the protocols with you. Jim On Sat, Apr 18, 2020 at 4:43 PM Penny Heaton @gatesmri.org> wrote: Dear Cliff and Jim, Greetings! I hope this weekend finds you with at least a moment to relax. By way of this email, I would like to introduce you to Jintanat Ananworanich. She is a pediatrician and immunologist, currently co-leading our RSV monoclonal antibody program among others. She has much clinical trial experience, particularly in LMICs. She declares she has a some additional bandwidth and would love to join you on the weekly team calls and help in any way she can. I will leave it to the three of you to coordinate from here. Best, Penny
  4. 2020-04-18 19:20 Jintanat Ananworanich open
    Inline-Images: image001.png Thank you Penny for the introduction. Dear Cliff and Jim, I am honored to be working with you on the protocols. Cliff, I agree it is under an unfortunate circumstance. Nevertheless it is a pleasure to work with you again. Jim, our paths crossed many years ago. I was at HIV-NAT and was a study physician on Esprit and other INSIGHT protocols in Thailand. David Cooper was a codirector at HIVNAT and we all miss him. I look forward to the call on Wednesday. Best regards, Jintanat Jintanat Ananworanich, M.D., Ph.D. Clinical Development Leader W M E @GatesMRI.org Bill & Melinda Gates Medical Research Institute 245 Main Street, Cambridge, MA 02142
  5. 2020-04-18 19:22 H. Clifford Lane
    Yes - outstanding physician. On Apr 18, 2020, at 7:14 PM, Jim Neaton @umn.edu> wrote: I recognize the name - was she involved in ESPRIT? On Sat, Apr 18, 2020 at 6:12 PM Lane, Cliff (NIH/NIAID) [E] @niaid.nih.gov> wrote: I think Mark knows her well. She used to work with Praphan and Kiat. On Apr 18, 2020, at 7:10 PM, Jim Neaton @umn.edu> wrote:  Thanks for the introduction Penny, and nice to meet you Jintanat. Look forward to talking to you on Wednesday and working on the protocols with you. Jim On Sat, Apr 18, 2020 at 4:43 PM Penny Heaton @gatesmri.org> wrote: Dear Cliff and Jim, Greetings! I hope this weekend finds you with at least a moment to relax. By way of this email, I would like to introduce you to Jintanat Ananworanich. She is a pediatrician and immunologist, currently co-leading our RSV monoclonal antibody program among others. She has much clinical trial experience, particularly in LMICs. She declares she has a some additional bandwidth and would love to join you on the weekly team calls and help in any way she can. I will leave it to the three of you to coordinate from here. Best, Penny
  6. 2020-04-18 19:47 Jim Neaton open
    Inline-Images: image001.png Yes, your name was familiar and I associated you with David but was not sure. Glad we are able to work together again in your new role. On Sat, Apr 18, 2020 at 6:20 PM Jintanat Ananworanich @gatesmri.org> wrote: Thank you Penny for the introduction. Dear Cliff and Jim, I am honored to be working with you on the protocols. Cliff, I agree it is under an unfortunate circumstance. Nevertheless it is a pleasure to work with you again. Jim, our paths crossed many years ago. I was at HIV-NAT and was a study physician on Esprit and other INSIGHT protocols in Thailand. David Cooper was a codirector at HIVNAT and we all miss him. I look forward to the call on Wednesday. Best regards, Jintanat Jintanat Ananworanich, M.D., Ph.D. Clinical Development Leader W M E @GatesMRI.org Bill & Melinda Gates Medical Research Institute BILL & MELINDA GATES MEDICAL RESEARCH INSTITUTE > > Look forward to talking to you on a > wrote: mt to relax. pediatrician and odwidth and 245 Main Street, Cambridge, MA 02142

Full conversation →